What is the fair value of Kraig Biocraft Labs (OTC-KBLB) stock?

The current fair value estimate for Kraig Biocraft Labs (OTC-KBLB) is $0.053. This implies an estimated downside of 26.7% versus the current market price.

Is Kraig Biocraft Labs (OTC-KBLB) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 26.7% versus the current market price.

How is the financial health of Kraig Biocraft Labs?

The current financial health read for Kraig Biocraft Labs (OTC-KBLB) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Kraig Biocraft Labs's next earnings date?

The next earnings date currently listed for Kraig Biocraft Labs (OTC-KBLB) is November 13, 2026.

Does Kraig Biocraft Labs (OTC-KBLB) pay dividends?

The latest available data indicates no current dividend yield for Kraig Biocraft Labs (OTC-KBLB).

What is the market capitalization of Kraig Biocraft Labs?

The current market capitalization listed for Kraig Biocraft Labs is 80.193 M.

What is the enterprise value of Kraig Biocraft Labs?

The current enterprise value listed for Kraig Biocraft Labs is 86.848 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Kraig Biocraft Labs?

The ticker symbol for Kraig Biocraft Labs is OTC-KBLB, and the stock is listed on OTC Markets.

Where is Kraig Biocraft Labs (OTC-KBLB) listed?

Kraig Biocraft Labs (OTC-KBLB) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Kraig Biocraft Labs?

The current debt-to-total-capital ratio listed for Kraig Biocraft Labs is 1.9%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Kraig Biocraft Labs?

The free float listed for Kraig Biocraft Labs is 76.4%. Free float helps investors understand how much of the share base is available for public trading.

Kraig Biocraft Labs (KBLB) Fair Value & Stock Analysis

Kraig Biocraft Labs (KBLB)

Kraig Biocraft Laboratories, Inc. is a common stock listing on OTC Markets for a company focused on developing protein-based fibers through recombinant DNA technology. Its work centers on spider silk-inspired materials produced in domesticated mulberry silkworms, including genetically engineered silkworms designed to express spider silk proteins. The company says these fibers are intended for use across a range of applications, such as performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, protective clothing, geotextiles, and transportation- and building-related textiles. Kraig Biocraft Laboratories was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-KBLB	$0.053	-26.7% Downside	Overvalued	Not available	Not available	Weak	0.0%	November 13, 2026	80.193 M	86.848 M	1.9%	76.4%	-19.6	50.2%